Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3816302A (SUIV) in Healthy Adults
NCT03275389Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2017
- Primary completion
- Mar 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 1, randomised, single-blind trial of D-SUIV cH5/1N1 in influenza (10 arms), sponsored by GSK. Primary endpoints: Number of Subjects With Solicited Local Adverse Events, Number of Subjects With Solicited General Adverse Events and 8 more. Started Sep 2017; status: completed.
02
Drugs
D-SUIV cH5/1N1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03275389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275389.